From the microarray analysis, we choose TGM2 for further study, because TGM2 has been reported as a prognostic marker for laryngeal cancer [19] or colorectal cancer [20] as well as a chemotherapy-resistance marker for breast cancer [21] and lung cancer [22]. Here, TGM2 is linked to lung carcinoma.